Request a Quote |
Login
Home > Company News > Evotec today announces a multi-year partnership with the Medical Center Hamburg-Eppendorf to develop iPSC-based tissue therapy for heart failure

Evotec today announces a multi-year partnership with the Medical Center Hamburg-Eppendorf to develop iPSC-based tissue therapy for heart failure

February 4th 2021

Read the press release from our parent company, Evotec.

Read more

Contact us

News categories

Archives

Contact us to discuss your ADME Tox issues or request a quote

Telephone:
North America (East Coast): +1-888-297-7683
Europe: +44 (0)1625 5051000

 

Email:
enquiries@cyprotex.com

or fill out the form below:

Please give details of the assays you are interested in. Where appropriate please specify one or more species (human, rat, mouse etc.), isoforms (CYP1A1,CYP1B1, etc) or other relevant details.

By clicking on ‘Send’ I agree that my data is being transferred and used by Cyprotex and the affiliated Evotec Group. The Evotec Group currently consists of the following companies. For further details please see our privacy policy.

If you would like to be kept informed of our latest services, new research, events and other news please tick the box below:

Close